# Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

Study · id `cardio:ct-nct05305612` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05305612](<https://clinicaltrials.gov/study/NCT05305612>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05305612

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 410 participants.

## Technical summary

Registry record NCT05305612. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-13 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 410 participants (planned count; ClinicalTrials.gov record NCT05305612, source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)
- Started: 2022-03-13 (actual) (ClinicalTrials.gov record NCT05305612, source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT05305612, source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)
- Completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT05305612, source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT05305612, source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05305612-2026-09-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
- Acronym: STOP CLOT
- Condition: Mitral Regurgitation
- Condition: Atrial Fibrillation
- Condition: Anticoagulation
- Intervention (Other): early anticoagulation
- Intervention (Other): late anticoagulation
- Lead sponsor: National Institute of Cardiology, Warsaw, Poland
- Lead sponsor class: OTHER
- Collaborator: Medical Research Agency, Poland
- Collaborator class: OTHER\_GOV
- Collaborator: Soft Communication, Poland
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: National Institute of Cardiology, Warsaw, Poland (`cardio:org-national-institute-of-cardiology-warsaw-poland`)
- Registry lists this organization as a collaborator: Medical Research Agency, Poland (`cardio:org-medical-research-agency-poland`)

## Provenance

Content hash: 814c5107773f34f4f5b7015e09814b88ccc3bc8eccb5b787e2435fc70664791c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
